SMTL ID : 2pl0.1

LCK bound to imatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.1: 17 residues within 4Å: Chain A: V.39, A.51, K.53, E.68, L.71, M.72, V.81, I.94, T.96, Y.98, M.99, I.141, H.142, L.151, A.161, D.162, F.163 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:A.51, A:E.68, A:V.81, A:I.94, A:M.99, A:L.151, A:D.162, A:F.163 Hydrogen bonds: A:E.68, A:T.96, A:D.162 Water bridges: A:I.141 Salt bridges: A:D.162 pi-Stacking: A:Y.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jacobs, M.D. et al., Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex. Proteins (2007)

Release Date

2007-10-09

Peptides

Proto-oncogene tyrosine-protein kinase LCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase LCK